Corbenic Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Sell
2022
Q1
$4K Sell
2021
Q4
$55K Sell
2021
Q3
$86K Hold
2021
Q2
$124K Hold
2021
Q1
$93K Buy